180 Life Sciences, rebranding as ETHZilla, surged over 200% after revealing $349 million in Ethereum reserves, a staking plan with Electric Capital, and a 7.5% stake from Peter Thiel's Founders Fund. The small-cap's shift from biotech to crypto treasury management ignited retail buzz, with message volume up 2,363% as traders bet on Ethereum-linked gains.